Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579953 · ClinicalTrials.gov registry record · Early Phase 1
Nicotine TMS EFT Smoking Pilot Study
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT03579953 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants.
The verdict
NCT03579953, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Prior and recent evidence suggests a role of medial prefrontal cortex (MPFC) in cigarette smoking. Episodic Future Thinking (EFT) has also been shown to be associated with increased delayed discounting and reduced cigarette self administration. In the present study, we will examine whether a single administration of theta-burst transcranial magnetic stimulation (tbTMS) can increase Episodic Future Thinking and delayed discounting while reducing craving for nicotine.
Interventions
- DEVICE Sham cTBS
- DEVICE Real cTBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2019-06-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03579953
The ClinicalTrials.gov registry entry for NCT03579953 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham cTBS is the first listed.
NCT03579953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03579953 about?
NCT03579953 is a clinical study titled "Nicotine TMS EFT Smoking Pilot Study". Prior and recent evidence suggests a role of medial prefrontal cortex (MPFC) in cigarette smoking. Episodic Future Thinking (EFT) has also been shown to be associated with increased delayed discounting and reduced cigarette self administration. In the present study, we will examine whether a single ...
What is the current status of trial NCT03579953?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2018-05-22. Estimated completion is 2019-06-10.
What interventions are being tested in trial NCT03579953?
The interventions under investigation include: Sham cTBS (DEVICE), Real cTBS (DEVICE).
Who is sponsoring clinical trial NCT03579953?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.